FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2104119940> ?p ?o ?g. }

• W2104119940 endingPage "2927" @default.
• W2104119940 startingPage "2919" @default.
• W2104119940 abstract "Estrogen (E2) has been shown to prevent bone loss among postmenopausal women. The molecular mechanism(s) by which this is accomplished is not clear. The discovery of E2 receptor (ER) in osteoblasts and osteoclasts has implicated these cells as direct targets for E2. Previous studies on the effects of E2 on osteoblastic cells in vitro or in organ culture present conflicting results, possibly due to heterogeneity in cell types, stage of differentiation, ER levels, and/or species differences. The effects of E2 on gene expression during various stages of human osteoblast cell differentiation has not been investigated extensively. In this study we employed a newly developed human fetal osteoblastic cell line (hFOB/ER9) that contains high levels of ER to examine the effects of E2 on osteoblast proliferation and differentiation. The basal levels and E2 effects on the expression of various extracellular matrix proteins were also characterized throughout different stages of differentiation. These stages include a proliferative/relatively undifferentiated stage (day 6), a matrix maturation stage (days 10-14), and a mineralization/calcified nodule stage (day 18). During the stage of rapid cell proliferation, E2 treatment of hFOB/ER9 cells resulted in a dose-dependent decrease in [3H]thymidine incorporation to a maximum of 72% compared to the vehicle control value. Treatment of hFOB/ER9 cells with 10(-9) M E2 for 48 h resulted in an increase in alkaline phosphatase (AP) activity throughout cell differentiation. The magnitude of AP induction varied from approximately 200-500%. In contrast, E2 decreased osteocalcin protein levels to a minimum of 54% compared to the vehicle control value. The steady state messenger RNA levels for AP increased and osteocalcin decreased after E2 treatment, similar to the responses observed at the protein level. At all stages, there was little or no effect of E2 on type I collagen protein levels or osteonectin steady state messenger RNA levels. The E2 responses on hFOB/ER9 cell matrix protein expression and cell proliferation were mediated through the ER, as cultures cotreated with a 100-fold molar excess of a type II anti-E2 (ICI 182,780) abrogated these effects. These results support the hypothesis that E2 does have an effect on osteoblastic differentiation by decreasing hFOB/ER9 cell proliferation and differentially regulating extracellular matrix expression." @default.
• W2104119940 created "2016-06-24" @default.
• W2104119940 creator A5029640432 @default.
• W2104119940 creator A5029833772 @default.
• W2104119940 creator A5054911795 @default.
• W2104119940 creator A5090023242 @default.
• W2104119940 date "1997-07-01" @default.
• W2104119940 modified "2023-10-10" @default.
• W2104119940 title "Estrogen Regulation of Human Osteoblastic Cell Proliferation and Differentiation*" @default.
• W2104119940 cites W1561293749 @default.
• W2104119940 cites W1966483713 @default.
• W2104119940 cites W1968506930 @default.
• W2104119940 cites W1991465946 @default.
• W2104119940 cites W1995664118 @default.
• W2104119940 cites W1998605268 @default.
• W2104119940 cites W2004236425 @default.
• W2104119940 cites W2011311044 @default.
• W2104119940 cites W2013276323 @default.
• W2104119940 cites W2021254365 @default.
• W2104119940 cites W2023205840 @default.
• W2104119940 cites W2025733870 @default.
• W2104119940 cites W2027978156 @default.
• W2104119940 cites W2037957091 @default.
• W2104119940 cites W2041852535 @default.
• W2104119940 cites W2043144329 @default.
• W2104119940 cites W2057346072 @default.
• W2104119940 cites W2062729355 @default.
• W2104119940 cites W2070458350 @default.
• W2104119940 cites W2070462923 @default.
• W2104119940 cites W2070656089 @default.
• W2104119940 cites W2076408697 @default.
• W2104119940 cites W2078455816 @default.
• W2104119940 cites W2084796745 @default.
• W2104119940 cites W2097339826 @default.
• W2104119940 cites W2132309525 @default.
• W2104119940 cites W2140086733 @default.
• W2104119940 cites W2143202678 @default.
• W2104119940 cites W2146135338 @default.
• W2104119940 cites W2157317148 @default.
• W2104119940 cites W2159051884 @default.
• W2104119940 cites W2164019859 @default.
• W2104119940 cites W4252543199 @default.
• W2104119940 doi "https://doi.org/10.1210/endo.138.7.5277" @default.
• W2104119940 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9202236" @default.
• W2104119940 hasPublicationYear "1997" @default.
• W2104119940 type Work @default.
• W2104119940 sameAs 2104119940 @default.
• W2104119940 citedByCount "99" @default.
• W2104119940 countsByYear W21041199402012 @default.
• W2104119940 countsByYear W21041199402013 @default.
• W2104119940 countsByYear W21041199402014 @default.
• W2104119940 countsByYear W21041199402018 @default.
• W2104119940 countsByYear W21041199402019 @default.
• W2104119940 countsByYear W21041199402020 @default.
• W2104119940 countsByYear W21041199402021 @default.
• W2104119940 countsByYear W21041199402022 @default.
• W2104119940 crossrefType "journal-article" @default.
• W2104119940 hasAuthorship W2104119940A5029640432 @default.
• W2104119940 hasAuthorship W2104119940A5029833772 @default.
• W2104119940 hasAuthorship W2104119940A5054911795 @default.
• W2104119940 hasAuthorship W2104119940A5090023242 @default.
• W2104119940 hasBestOaLocation W21041199401 @default.
• W2104119940 hasConcept C104317684 @default.
• W2104119940 hasConcept C126322002 @default.
• W2104119940 hasConcept C131075544 @default.
• W2104119940 hasConcept C134018914 @default.
• W2104119940 hasConcept C148738053 @default.
• W2104119940 hasConcept C160160445 @default.
• W2104119940 hasConcept C181199279 @default.
• W2104119940 hasConcept C185592680 @default.
• W2104119940 hasConcept C189165786 @default.
• W2104119940 hasConcept C202751555 @default.
• W2104119940 hasConcept C2777164284 @default.
• W2104119940 hasConcept C2778260815 @default.
• W2104119940 hasConcept C54355233 @default.
• W2104119940 hasConcept C55493867 @default.
• W2104119940 hasConcept C62112901 @default.
• W2104119940 hasConcept C71924100 @default.
• W2104119940 hasConcept C81885089 @default.
• W2104119940 hasConcept C86803240 @default.
• W2104119940 hasConcept C95444343 @default.
• W2104119940 hasConceptScore W2104119940C104317684 @default.
• W2104119940 hasConceptScore W2104119940C126322002 @default.
• W2104119940 hasConceptScore W2104119940C131075544 @default.
• W2104119940 hasConceptScore W2104119940C134018914 @default.
• W2104119940 hasConceptScore W2104119940C148738053 @default.
• W2104119940 hasConceptScore W2104119940C160160445 @default.
• W2104119940 hasConceptScore W2104119940C181199279 @default.
• W2104119940 hasConceptScore W2104119940C185592680 @default.
• W2104119940 hasConceptScore W2104119940C189165786 @default.
• W2104119940 hasConceptScore W2104119940C202751555 @default.
• W2104119940 hasConceptScore W2104119940C2777164284 @default.
• W2104119940 hasConceptScore W2104119940C2778260815 @default.
• W2104119940 hasConceptScore W2104119940C54355233 @default.
• W2104119940 hasConceptScore W2104119940C55493867 @default.
• W2104119940 hasConceptScore W2104119940C62112901 @default.
• W2104119940 hasConceptScore W2104119940C71924100 @default.
• W2104119940 hasConceptScore W2104119940C81885089 @default.

• next